BRIEF: Burning Rock returns to revenue growth as loss narrows
Cancer screening company Burning Rock Biotech Ltd. (BNR.US) on Wednesday reported its revenue rose 0.8% in the third quarter year-on-year to 128.6 million yuan ($17.6 million), as it returned to…
BNR.US
Recent Articles
RELATED ARTICLES
- Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
GenScript losses shrink on strong growth for cancer cell therapy
1548.HK
-
Inaugural operating profit fails to lift 111 Inc.
YI.US
-
New Horizon Health launches probe into disputed sales figures
6606.HK
- Sunho Biologics gets green light for downsized IPO
- Bayzed joins IPO quest as medical rivalry heats up
Discover hidden China stock gems in our weekly newsletter